1-173825320-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018122.5(DARS2):āc.91A>Gā(p.Arg31Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_018122.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DARS2 | NM_018122.5 | c.91A>G | p.Arg31Gly | missense_variant | 1/17 | ENST00000649689.2 | NP_060592.2 | |
DARS2 | NM_001365212.1 | c.91A>G | p.Arg31Gly | missense_variant | 1/16 | NP_001352141.1 | ||
DARS2 | NM_001365213.2 | c.91A>G | p.Arg31Gly | missense_variant | 1/14 | NP_001352142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DARS2 | ENST00000649689.2 | c.91A>G | p.Arg31Gly | missense_variant | 1/17 | NM_018122.5 | ENSP00000497569 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000437 AC: 11AN: 251472Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135918
GnomAD4 exome AF: 0.000237 AC: 347AN: 1461628Hom.: 0 Cov.: 30 AF XY: 0.000228 AC XY: 166AN XY: 727130
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 03, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1397631). This variant has not been reported in the literature in individuals affected with DARS2-related conditions. This variant is present in population databases (rs140881109, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 31 of the DARS2 protein (p.Arg31Gly). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 14, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2021 | The c.91A>G (p.R31G) alteration is located in exon 1 (coding exon 1) of the DARS2 gene. This alteration results from a A to G substitution at nucleotide position 91, causing the arginine (R) at amino acid position 31 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at